Academic Journal
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
| العنوان: | Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic |
|---|---|
| المؤلفون: | Cavalieri S, Colombo E, Bottiglieri A, Massa G, Platini F, Ottini A, Filippini DM, Zattarin E, Bergamini C, Resteghini C, Alfieri S, Di Martino V, Tiraferri V, Locati LD, Licitra L. |
| المساهمون: | S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra |
| سنة النشر: | 2021 |
| المجموعة: | The University of Milan: Archivio Istituzionale della Ricerca (AIR) |
| مصطلحات موضوعية: | COVID-19, SARS-CoV-2, head and neck cancer, triage, Settore MED/06 - Oncologia Medica |
| الوصف: | Objective: To capture and monitor flu-like symptoms in relation to the clinical characteristics and the oncologic treatment of a large head and neck cancer (HNC) patient cohort during the Coronavirus disease 2019 (COVID-19) pandemic. Methods: Patients were monitored through by 2 rounds of interviews. Clinical characteristics of patients with no symptoms (group 0) and of those reporting ⩾1 (group A), ⩾3 (group B), or ⩾5 symptoms (group C) were analyzed. Patients with ⩾1 symptom at both interviews were defined as group A2. Results: Five hundred patients with HNC were analyzed. A higher frequency of patients with the following characteristics was observed in group A vs group 0: active treatment (40% vs 24%, p = 0.0002), gastrostomy (6% vs 2%, p = 0.027), recent active treatment (48% vs 29%, p < 0.0001), and higher number of concomitant medications (p = 0.01). A lower median age was observed in group B vs group no-B (patients with fewer than three symptoms) (59 vs 63.55 years, p = 0.016) and in group A2 vs group no-A2 (patients without at least one symptom at both interviews) (56 vs 63 years, p = 0.021); patients in group B received more recent active treatment than those in group no-B and in group A2 vs those in group no-A2 (p = 0.024 and 0.043, respectively); patients in group B had a lower body mass index than those in group no-B (22.4 vs 23.93 kg/m2 , p = 0.0066). Conclusions: This work is based on patient-reported symptoms and signs independently of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing. In the future, these results might serve as a a benchmark for clinicians triaging and managing patients with HNC during infectious outbreaks involving flu-like symptoms. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/33849307; info:eu-repo/semantics/altIdentifier/wos/WOS:000678100300001; journal:TUMORI; http://hdl.handle.net/2434/836476; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104277725 |
| DOI: | 10.1177/03008916211007940 |
| الاتاحة: | http://hdl.handle.net/2434/836476 https://doi.org/10.1177/03008916211007940 |
| Rights: | info:eu-repo/semantics/closedAccess |
| رقم الانضمام: | edsbas.3A019933 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1177/03008916211007940 |
|---|